Technology
Health
Biotechnology

Aimmune Therapeutics

1,732

$26.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.16 (-0.60%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell AIMT and other stocks, options, ETFs, and crypto commission-free!

About AIMT

Aimmune Therapeutics, Inc. Common Stock, also called Aimmune Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Read More Its portfolio includes the characterized oral desensitization immunotherapy system. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA.

CEO
Jayson Donald Alexander Dallas
Employees
215
Headquarters
Brisbane, California
Founded
2011
Market Cap
1.69B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
616.13K
High Today
$27.09
Low Today
$26.46
Open Price
$27.09
Volume
568.38K
52 Week High
$31.83
52 Week Low
$16.95

Collections

Technology
Health
Biotechnology
Therapy
Medical
Biopharmaceutical
Research And Development
Food

AIMT News

ReutersNov 14

Edited Transcript of AIMT earnings conference call or presentation 6-Nov-19 9:30pm GMT

Q3 2019 Aimmune Therapeutics Inc Earnings Call Brisbane Nov 15, 2019 (Thomson StreetEvents) -- Edited Transcript of Aimmune Therapeutics Inc earnings conferenc
2

AIMT Earnings

-$1.03
-$0.92
-$0.82
-$0.71
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
-$1.03 per share
Replay Earnings Call

You May Also Like

GRTS
BML-L
CPYYY
ROLL
WD
VIIX
FDEF
VQT
ISRG
AZUL
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy AIMT

Market Price$26.67
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell AIMT stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up